These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metronomic chemotherapy: Back to the future! André N; Padovani L; Verschuur A Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic scheduling of lower dose cancer chemotherapy. Gately S; Kerbel R Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902 [TBL] [Abstract][Full Text] [Related]
5. The combination of antiangiogenic therapy with other modalities. O'Reilly MS Cancer J; 2002; 8 Suppl 1():S89-99. PubMed ID: 12075706 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic cancer therapy. Cao Y Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis research: from laboratory to clinic. Folkman J Forum (Genova); 1999; 9(3 Suppl 3):59-62. PubMed ID: 10607848 [TBL] [Abstract][Full Text] [Related]
8. The interaction of radiation therapy and antiangiogenic therapy. O'Reilly MS Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126 [TBL] [Abstract][Full Text] [Related]
9. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment. Gagne P; Akalu A; Brooks PC Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis. Folkman J; Ingber D Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314 [TBL] [Abstract][Full Text] [Related]
11. [Angiogenesis and antiangiogenic cancer therapy]. Pour L; Hájek R; Buchler T; Maisnar V; Smolej L Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and antiangiogenic therapy in hematologic malignancies. Dong X; Han ZC; Yang R Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504 [TBL] [Abstract][Full Text] [Related]
14. Angiogenesis inhibition in solid tumors. Rosen LS Cancer J; 2001; 7 Suppl 3():S120-8. PubMed ID: 11779082 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells. Bertolini F Cancer Metastasis Rev; 2008 Mar; 27(1):95-101. PubMed ID: 18066648 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms and therapeutic development of angiogenesis inhibitors. Cao Y Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094 [TBL] [Abstract][Full Text] [Related]
18. Metronomic dosing of chemotherapy: applications in pediatric oncology. Stempak D; Seely D; Baruchel S Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697 [TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. Samuel DP; Wen PY; Kieran MW Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852 [TBL] [Abstract][Full Text] [Related]
20. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer. Roukos DH; Tzakos A; Zografos G Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000 [No Abstract] [Full Text] [Related] [Next] [New Search]